EUVIMEDEUVIMED entdecken
Crossref

Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression

Swati Ghosh, Michael W Devereaux, Colin C Anderson, David J Orlicky, Ronald J Sokol

World Journal of Gastroenterology · 14.01.2027 · 33 (2)

DOI: 10.3748/wjg.125044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 14.01.2027. Verfasst von Swati Ghosh und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Chronic inflammatory cholangiopathies involve bile duct injury, biochemical cholestasis, hepatocellular injury, immune cell recruitment, oxidative stress, and fibrogenic remodeling. We previously demonstrated that 20% dietary lauric acid (LA) protected against early 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced cholangiopathy (proof of concept) by activating liver receptor homolog-1 (LRH-1). AIM To determine whether concurrent low-dose 5% dietary LA supplementation attenuates 14-day DDC-induced cholangiopathy and to characterize the associated inflammatory and metabolic responses. METHODS Eight-week-old male C57BL/6J mice were fed for 14 days with either Chow, 0.1% DDC, 5% LA, or a 0.1% DDC diet supplemented with 5% LA. RESULTS DDC feeding induced severe hepatocellular and cholestatic liver injury, macrophage infiltration, ductular reaction, oxidative stress, hepatocyte senescence, and fibrogenic remodeling. LA supplementation significantly reduced DDC-induced elevations of serum aminotransferases, bilirubin, and total bile acids, and decreased hepatic F4/80-positive macrophage infiltration and Picrosirius red collagen staining. LA supplementation restored hepatic expression of LRH-1-dependent genes involved in bile acid homeostasis, which DDC suppressed. Furthermore, DDC suppressed ileal farnesoid X receptor-fibroblast growth factor 15 signaling, which LA normalized, and LA attenuated DDC-induced hepatic oxidative and nitrosative stress and improved the expression of mitochondrial fatty acid metabolism genes. LA was associated with suppressed hepatic fibrosis markers and promoted anti-inflammatory macrophage genetic signatures. Notably, DDC activated nuclear factor-kappa B binding to the C-C motif chemokine ligand 2 promoter and repressed LRH-1 transcription, which were reversed by LA supplementation. CONCLUSION Dietary LA attenuated chronic DDC cholangiopathy which was associated with reduced nuclear factor-kappa B-dependent inflammatory signaling and restoring LRH-1-mediated bile acid homeostasis. This positions LA as a potential therapeutic strategy for inflammatory cholangiopathy.

Zitieren

APA

Ghosh, S., Devereaux, M. W., Anderson, C. C., Orlicky, D. J., & Sokol, R. J. (2027). Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression. World Journal of Gastroenterology, 33(2). https://doi.org/10.3748/wjg.125044

Vancouver

Ghosh S, Devereaux MW, Anderson CC, Orlicky DJ, Sokol RJ. Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression. World Journal of Gastroenterology. 2027;33(2). doi:10.3748/wjg.125044

BibTeX
@article{Ghosh2027,
  author = {Ghosh, Swati and Devereaux, Michael W and Anderson, Colin C and Orlicky, David J and Sokol, Ronald J},
  title = {Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression},
  journal = {World Journal of Gastroenterology},
  year = {2027},
  volume = {33},
  number = {2},
  doi = {10.3748/wjg.125044}
}
Kostenlos starten →